News

Regeneron Pharmaceuticals will present data from 14 studies at ASH 2025 in Orlando, showcasing major advances in treatments for multiple myeloma, lymphoma, and rare blood disorders. Key highlights include promising results for its bispecific antibody Lynozyfic and progress in the odronextamab and cemdisiran–pozelimab programs, reinforcing Regeneron’s leadership in hematology innovation. [...]

Bitcoin prices slipped nearly 2% to $93,684 on Sunday as investors grew cautious ahead of key U.S. economic data and central bank updates. The dip highlights renewed volatility in the cryptocurrency market, with traders balancing short-term risks against long-term optimism. Analysts say upcoming financial and policy developments will shape Bitcoin?s next move. [...]

The FDA has approved Poherdy (pertuzumab-dpzb) as the first interchangeable biosimilar to Perjeta, marking a major milestone for HER2-positive breast cancer care. Developed by Shanghai Henlius Biologics, Poherdy can be used in metastatic, neoadjuvant, and adjuvant treatment settings in combination with trastuzumab and chemotherapy. FDA’s decision was based on extensive structural, functional [...]

The UK has revised its UK-China Tech Collab to limit joint research in high-risk areas such as robotics, satellite technology, and remote sensing. The updated framework focuses on safer fields—including climate science, agriculture, health, and planetary exploration—balancing innovation with national security. While funding and project scope are narrower than before, both nations remain commi [...]

Global cloud providers are accelerating investments and launching AI-driven innovations. AWS, Microsoft, Google, IBM, Oracle, Alibaba, and Tencent focus on security, scalability, and compliance to power the next wave of digital transformation and AI adoption [...]

The UK government is preparing new regulations requiring stricter pre-deployment testing of AI systems to prevent the creation of child abuse imagery. The initiative aims to ensure accountability, enhance AI safety, and strengthen international cooperation. Officials will work with Ofcom, the Home Office, and child protection groups to enforce compliance and promote responsible AI innovation. [...]

AMD projects a major leap in growth, expecting its data center revenue to hit $100 billion by 2030, driven by soaring AI demand. CEO Lisa Su outlined bold expansion plans, new AI chip launches, and strategic acquisitions positioning AMD as a strong challenger to Nvidia in the trillion-dollar AI chip race.  [...]

Canada has lost its measles elimination status after over a year of continuous transmission and 5,100 cases. Officials blame declining vaccination rates and misinformation, urging renewed immunization and surveillance to regain control. Experts warn the U.S. could face similar risks if coverage continues to slip.  [...]

Microsoft will invest around $10 billion in a major AI data center near Sines, Portugal, partnering with Start Campus, Nscale, and NVIDIA. The project aims to strengthen Europe’s AI and cloud infrastructure, leveraging renewable energy and subsea connectivity. It is expected to create jobs, support sustainability goals, and position Portugal as a European AI hub.  [...]

Dupixent (dupilumab) achieved all primary and secondary endpoints in a pivotal Phase 3 trial for children aged six months to five years with moderate-to-severe atopic dermatitis. The treatment significantly improved skin clearance, reduced itching, and enhanced quality of life. With a strong safety profile, Dupixent may soon be approved for infants, offering a new breakthrough therapy for pediatri [...]